4月16日，据CDE官网消息，江苏恩华药业股份有限公司联合申请药品“盐酸左米那普仑缓释胶囊”，获得临床试验默示许可，受理号CYHL2400029。
公示信息显示，药品“盐酸左米那普仑缓释胶囊”适应症：本品适用于成人抑郁症（MDD）的治疗。 。
江苏恩华药业股份有限公司药品申请临床试验默示许可获受理
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.